Understanding how sugar molecules on antibodies relate to Alzheimer's Disease
Deciphering the IgG glycosylation code of Alzheimer's Disease
This study is looking at how sugar molecules attached to antibodies might affect the immune system in people with Alzheimer's Disease, hoping to find clues that could lead to better treatments and ways to track the disease's progress.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11014374 on NIH RePORTER |
What this research studies
This research investigates the role of glycosylation, the process of adding sugar molecules to antibodies, in the context of Alzheimer's Disease. By analyzing how different glycoforms of IgG antibodies interact with immune receptors, the study aims to uncover their potential impact on the immune response in Alzheimer's patients. The researchers will utilize advanced techniques to assess the glycosylation patterns of antibodies over time, correlating these patterns with disease progression and severity. This approach may help identify biomarkers for Alzheimer's and improve therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's Disease, particularly those in the early to moderate stages.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new diagnostic tools and treatments that enhance the immune response in Alzheimer's Disease.
How similar studies have performed: Previous research has shown promising results in understanding antibody glycosylation in other diseases, suggesting potential for success in this novel approach for Alzheimer's.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Sundberg, Eric John — Emory University
- Study coordinator: Sundberg, Eric John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.